SCHEMBL7938411

SCHEMBL7938411

COc1ccc2c(c1)NCC2C(=O)C(=O)N(CC1CCCCC1)C(C)(C)C(=O)NC1CCOCC1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
HPGDS O60760 1/20 0.35
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
POLB P06746 2/20 0.33
CNR2 P34972 2/20 0.33
CNR1 P21554 1/20 0.33
EPHX2 P34913 1/20 0.33
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
MAPK10 P53779 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7993224 0.84 MEN1 (0.42) NPC1RAB9AKMT2AMEN1CYP1A2
SCHEMBL7985982 0.79 KMT2A (0.40) NPC1RAB9AKMT2AMEN1CYP1A2
SCHEMBL7951886 0.78 MITF (0.45) NPC1RAB9AKMT2AMEN1CYP1A2
SCHEMBL7946743 0.78 MITF (0.45) NPC1RAB9AKMT2AMEN1CYP1A2
SCHEMBL7947062 0.78 MITF (0.43) NPC1RAB9AKMT2AMEN1CYP1A2
SCHEMBL7948614 0.78 POLB (0.40) NPC1RAB9APOLBEPHX2ALDH1A1
SCHEMBL7938405 0.75 FKBP1A (0.38) KMT2AMEN1CYP3A4CYP2C19POLB
SCHEMBL7998793 0.75 MITF (0.41) NPC1RAB9AKMT2AMEN1CYP1A2
SCHEMBL7948016 0.74 POLB (0.38) NPC1RAB9AKMT2AMEN1CYP1A2
SCHEMBL7947164 0.74 PLA2G2A (0.37) NPC1RAB9AKMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010035032-A1 CALCIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2010-04-01 WO disclosed
WO-2009133387-A1 INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS LECTUS THERAPEUTICS LIMITED (GB) 2009-11-05 WO disclosed